ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.
Zacks·23d ago
Compared to Estimates, Alcon (ALC) Q2 Earnings: A Look at Key Metrics
The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·25d ago
Stay Ahead of the Game With Alcon (ALC) Q2 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Alcon (ALC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Zacks·1mo ago
Alcon Stock Gains Following UNITY VCS' Approval in Canada
ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology.
Zacks·2mo ago
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.
Zacks·2mo ago
Do Options Traders Know Something About Alcon Stock We Don't?
Investors need to pay close attention to ALC stock based on the movements in the options market lately.
Zacks·2mo ago
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?
ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.
Investing.com -- In a note to clients on Thursday, UBS analysts assessed "The Next Big Thing" in global equities, focusing on companies that leverage technology to disrupt various sectors.